scholarly article | Q13442814 |
P50 | author | György Szekeres | Q114073677 |
P2093 | author name string | Zoltán Janka | |
Szabolcs Kéri | |||
Anna Juhász | |||
Agnes Rimanóczy | |||
P2860 | cites work | The positive and negative syndrome scale (PANSS) for schizophrenia | Q28301751 |
Implications of normal brain development for the pathogenesis of schizophrenia | Q29618740 | ||
Challenges, status, and opportunities for studying developmental neuropathology in adult schizophrenia | Q34398932 | ||
Genetic insights into the neurodevelopmental hypothesis of schizophrenia | Q34398940 | ||
Developmental and stress-related changes of neurotrophic factor gene expression in an animal model of schizophrenia | Q43590751 | ||
Association study of schizophrenia with polymorphisms at six candidate genes | Q43601609 | ||
BDNF mRNA expression in rat hippocampus and prefrontal cortex: effects of neonatal ventral hippocampal damage and antipsychotic drugs | Q43698142 | ||
No linkage or linkage disequilibrium between brain-derived neurotrophic factor (BDNF) dinucleotide repeat polymorphism and schizophrenia in Irish families | Q48326388 | ||
Brain-derived neurotrophic factor and neurotrophin 3 in schizophrenic psychoses | Q48752188 | ||
A novel polymorphism of the brain-derived neurotrophic factor (BDNF) gene associated with late-onset Alzheimer's disease | Q48956972 | ||
Heritability of BDNF alleles and their effect on brain morphology in schizophrenia. | Q51979638 | ||
Brain Derived Neurotrophic Factor (BDNF) gene variants association with age at onset and therapeutic response in schizophrenia | Q59668718 | ||
Brain-derived neurotrophic factor and tyrosine kinase receptor TrkB in rat brain are significantly altered after haloperidol and risperidone administration | Q73911873 | ||
Abnormal expression of brain-derived neurotrophic factor and its receptor in the corticolimbic system of schizophrenic patients | Q73978751 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | schizophrenia | Q41112 |
schizophrenic psychology | Q69941090 | ||
P304 | page(s) | 15-18 | |
P577 | publication date | 2003-12-01 | |
P1433 | published in | Schizophrenia Research | Q7431607 |
P1476 | title | The C270T polymorphism of the brain-derived neurotrophic factor gene is associated with schizophrenia | |
P478 | volume | 65 |
Q36600804 | A Review of Brain-derived Neurotrophic Factor as a Candidate Biomarker in Schizophrenia |
Q46437247 | Age-dependent spontaneous hyperexcitability and impairment of GABAergic function in the hippocampus of mice lacking trkB. |
Q44570590 | An association study of a brain-derived neurotrophic factor Val66Met polymorphism and clozapine response of schizophrenic patients |
Q45207542 | Association analysis of the dopamine D3 receptor gene ser9gly and brain-derived neurotrophic factor gene val66met polymorphisms with antipsychotic-induced persistent tardive dyskinesia and clinical expression in Chinese schizophrenic patients |
Q43947014 | Association of the BDNF C270T polymorphism with schizophrenia: updated meta-analysis |
Q37249757 | Association study between BDNF gene polymorphisms and autism by three-dimensional gel-based microarray. |
Q42157677 | BDNF and schizophrenia: from neurodevelopment to neuronal plasticity, learning, and memory |
Q34385320 | BDNF in schizophrenia, depression and corresponding animal models |
Q40688564 | BDNF rescues prefrontal dysfunction elicited by pyramidal neuron-specific DTNBP1 deletion in vivo. |
Q33854887 | BDNF variants, premorbid educational attainment, and disease characteristics in Alzheimer's disease: an exploratory study |
Q36938204 | Brain derived neurotrophic factor (BDNF) gene variants and Alzheimer's disease, affective disorders, posttraumatic stress disorder, schizophrenia, and substance dependence |
Q35847085 | Brain-derived neurotrophic factor and neuropsychiatric disorders |
Q36756397 | Brain-derived neurotrophic factor in schizophrenia and its relation with dopamine |
Q48967630 | Brain-derived neurotrophic factor val66met polymorphism and volume of the hippocampal formation. |
Q37078047 | Brain-derived neurotropic factor/TrkB signaling in the pathogenesis and novel pharmacotherapy of schizophrenia |
Q34987347 | Cell biology of BDNF and its relevance to schizophrenia |
Q35882092 | Cognitive effects of cytotoxic cancer chemotherapy: predisposing risk factors and potential treatments |
Q36567277 | DNA Methylation of BDNF Gene in Schizophrenia. |
Q46652776 | Drugs acting on D3 receptors in neuropsychiatric disorders: facts and prospects. Implication for schizophrenia and its treatment in the regulation of BDNF-dependence on D3 receptor expression |
Q39884103 | Effect of BDNF Val66Met polymorphism on digital working memory and spatial localization in a healthy Chinese Han population |
Q35028299 | Evidence for Association between the Brain-Derived Neurotrophic Factor Gene and Panic Disorder: A Novel Haplotype Analysis. |
Q35894474 | Expanding the 'central dogma': the regulatory role of nonprotein coding genes and implications for the genetic liability to schizophrenia |
Q39315740 | Expression and methylation of BDNF in the human brain in schizophrenia |
Q34431154 | Genetic models of schizophrenia and bipolar disorder: overlapping inheritance or discrete genotypes? |
Q38844917 | Genetic polymorphisms and the adequacy of brain stimulation: state of the art. |
Q36401916 | Imaging genomics and response to treatment with antipsychotics in schizophrenia. |
Q35689150 | Personalized psychiatry: a realistic goal |
Q36341739 | Pharmacogenomics: a path to predictive medicine for schizophrenia |
Q35712176 | Postmortem investigations of the pathophysiology of schizophrenia: the role of susceptibility genes |
Q34347578 | Relationship between brain-derived neurotrophic factor gene C270T polymorphisms and the psychotic symptoms and cognitive functioning of patients with schizophrenia |
Q48538370 | Specificity and timing of neocortical transcriptome changes in response to BDNF gene ablation during embryogenesis or adulthood |
Q48375775 | The G196A polymorphism of the brain-derived neurotrophic factor gene and the antidepressant effect of milnacipran and fluvoxamine |
Q33624412 | Theranostic Biomarkers for Schizophrenia |
Q46632689 | [Brain-derived neurotrophic factor: from nerve growth factor to modulator of brain plasticity in cognitive processes and psychiatric diseases]. |